EDIT:NASDAQ
Editas Medicine Inc
၂.၁၇ US$
arrow_upward
+၁.၄၀%(+၀.၀၃၀) 1D
နို ၁၃, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
၂.၁၄ US$
High
၂.၂၁ US$
Low
၂.၀၁ US$
Mkt. cap
၃၃.၄၉ ကုဋေ
Avg. vol.
၂.၄၂ သန်း
Volume
၂.၇၉ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
Open
၂.၁၄ US$
High
၂.၂၁ US$
Low
၂.၀၁ US$
Mkt. cap
၃၃.၄၉ ကုဋေ
Avg. vol.
၂.၄၂ သန်း
Volume
၂.၇၉ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
Key facts: Tesla Merger Talks; $29,990 Cybercab Offer; S&P 500 Impact
www.tokenpost.com
·
ပြီးခဲ့သည့် ၁၆ မိနစ်
Ava Labs Says Avalanche Will Provide Ledger for NYSE-Linked Securities Venue
Traders Union
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
Gate.io announces indicative USDT subscriptions for Anthropic IPO ahead of Nasdaq listing
AP News
·
ပြီးခဲ့သည့် ၁ ရက်
Microsoft outage shows the risks of relying on a single technology provider for essential services
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc